Bayer Wants Patient Engagement in Early Drug Development
Bayer is collaborating with MD Anderson in Texas to develop a questionnaire that will query a patient's disease-related symptoms, a step to include PROs in early drug development which could help reduce adverse effects in the final product.
HHS' Balancing Act to Keep Healthcare Costs Down
The proposed federal guidelines are currently open for feedback are calling for greater transparency with informed consent and CER, which might stifle innovation, according to some advocacy groups.
The Value of Ultrasound in Breast Cancer Detection
A study conducted in Connecticut showed that ultrasound identified an additional 3.2 women in a 1000 with breast cancer, following a negative mammogram. This has raised a debate on the utility of a screening ultrasound.
Narrow Networks at a Flash Point in California
With healthcare payers increasingly relying on narrow provider networks to contain costs and achieve quality, California regulators are pressing health plans to blunt out-of-network costs and maintain accurate provider directories.
Medicaid Reimbursement Increases Improved Access to Care
The Affordable Care Act’s mandate to increase Medicaid reimbursement to primary care providers has improved access to care for Medicaid enrollees, according to analysis of early evidence published in the New England Journal of Medicine
Rigid Cancer Cells Prevent Metastasis, Study Finds
Existing cancer therapies are geared toward massacring tumor cells, but researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body. They devised a way of screening compounds for the desired effect and have identified a compound that shows promise in fighting pancreatic cancer.